Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

First in Human Clinical Trial of the PAVmed PortIO Intraosseous Infusion System to Evaluate Safety and Performance

NCT06037265 is registered in ClinicalTrials.gov with PAVmed Inc. as lead sponsor.

NCT NCT06037265
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06037265 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
First in Human Clinical Trial of the PAVmed PortIO Intraosseous Infusion System to Evaluate Safety and Performance
Lead sponsor
PAVmed Inc.
Phase
Not applicable
Overall status
Completed
Start date
January 20, 2022
Completion date
July 29, 2024
Enrollment
15 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney disease stage 5, chronic kidney disease stage3, chronic kidney disease stage4, poor vascular access